SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Zhang YM) "

Sökning: WFRF:(Zhang YM)

  • Resultat 1-10 av 140
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • He, YQ, et al. (författare)
  • A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening
  • 2022
  • Ingår i: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 13:1, s. 1966-
  • Tidskriftsartikel (refereegranskat)abstract
    • Polygenic risk scores (PRS) have the potential to identify individuals at risk of diseases, optimizing treatment, and predicting survival outcomes. Here, we construct and validate a genome-wide association study (GWAS) derived PRS for nasopharyngeal carcinoma (NPC), using a multi-center study of six populations (6 059 NPC cases and 7 582 controls), and evaluate its utility in a nested case-control study. We show that the PRS enables effective identification of NPC high-risk individuals (AUC = 0.65) and improves the risk prediction with the PRS incremental deciles in each population (Ptrend ranging from 2.79 × 10−7 to 4.79 × 10−44). By incorporating the PRS into EBV-serology-based NPC screening, the test’s positive predictive value (PPV) is increased from an average of 4.84% to 8.38% and 11.91% in the top 10% and 5% PRS, respectively. In summary, the GWAS-derived PRS, together with the EBV test, significantly improves NPC risk stratification and informs personalized screening.
  •  
8.
  •  
9.
  • Ruilope, LM, et al. (författare)
  • Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
  • 2019
  • Ingår i: American journal of nephrology. - : S. Karger AG. - 1421-9670 .- 0250-8095. ; 50:5, s. 345-356
  • Tidskriftsartikel (refereegranskat)abstract
    • <b><i>Background:</i></b> Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. <b><i>Patients and</i></b> <b><i>Methods:</i></b> The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate ≥25 mL/min/1.73 m<sup>2</sup> and albuminuria (urinary albumin-to-creatinine ratio ≥30 to ≤5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level α = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. <b><i>Conclusions:</i></b> FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 140
Typ av publikation
tidskriftsartikel (136)
konferensbidrag (1)
Typ av innehåll
refereegranskat (127)
övrigt vetenskapligt/konstnärligt (10)
Författare/redaktör
Fischer, F (36)
Jonas, JB (35)
Kim, YJ (35)
Shaikh, MA (35)
Mohammed, S (34)
Mokdad, AH (34)
visa fler...
Arabloo, J (32)
Samy, AM (32)
Singh, JA (32)
Olagunju, AT (31)
Kisa, A (30)
Zhang, Z. (29)
Dandona, R (29)
Hay, SI (29)
Ilesanmi, OS (29)
Jha, RP (29)
Khan, M (29)
Koyanagi, A (29)
Negoi, I (29)
Radfar, A (29)
Rawaf, S (29)
Dandona, L (28)
Filip, I (28)
Hosseinzadeh, M (28)
Mestrovic, T (28)
Gupta, R. (27)
Bijani, A (27)
Guo, YM (27)
Khan, EA (27)
Mansournia, MA (27)
Monasta, L (27)
Banach, M (26)
Bhattacharyya, K (26)
Diaz, D (26)
Islam, SMS (26)
Khader, YS (26)
Krishan, K (26)
Kumar, GA (26)
Mirrakhimov, EM (26)
Shigematsu, M (26)
Butt, ZA (25)
Fukumoto, T (25)
Hamidi, S (25)
Jozwiak, JJ (25)
Li, SS (25)
Majeed, A (25)
Nangia, V (25)
Renzaho, AMN (25)
Sahebkar, A (25)
Sathian, B (25)
visa färre...
Lärosäte
Karolinska Institutet (138)
Uppsala universitet (32)
Lunds universitet (20)
Högskolan Dalarna (13)
Göteborgs universitet (11)
Umeå universitet (10)
visa fler...
Jönköping University (4)
Linköpings universitet (3)
Kungliga Tekniska Högskolan (2)
Stockholms universitet (2)
Högskolan i Skövde (2)
Chalmers tekniska högskola (2)
Örebro universitet (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (140)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (54)
Naturvetenskap (4)
Teknik (1)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy